For automotive manufacturers and auto parts suppliers, obtaining component cleanliness results rapidly, accurately, and reproducibly over the entire workflow is a significant advantage. Making it easier to build up facilities, knowledge and expertise in component cleanliness Pall and Leica can offer unique workflow solutions fitting to individual needs and compliant with common standards. Often for... Read more
The quality of steel is an essential topic in automotive, metalworking and building industries. To ensure the highest standards, an accurate and reliable Quality Assurance workflow for the inspection of non-metallic inclusions is crucial. Leica Microsystems offers state-of-the-art and individualized microscopy solutions, allowing you to inspect the microstructure and evaluate the non-metallic inclusion content of... Read more
Download PDF Read more
Download PDF Read more
Offer Now Scheduled to Expire at 5:00 p.m., New York City Time, on August 28, 2017 Read more
Waukesha, WI – August 4, 2017 – GE Healthcare (NYSE: GE) is proud to announce SIGNA™ Premier, a new wide bore 3.0T magnetic resonance imaging (MRI) system, is now available for sale in the U.S. SIGNA Premier is the result of a four-year collaboration with the National Football League (NFL) and research institutions around the world... Read more
Basel, 03 August 2017 FDA grants Roche’s Alecensa Priority Review for initial treatment of people with ALK-positive lung cancer Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has accepted the company’s supplemental New Drug Application (sNDA) and granted Priority Review for Alecensa® (alectinib) as an initial (first-line)... Read more
BILLERICA, Mass., July 31, 2017 /PRNewswire/ — Bruker today announces that it has received US Food & Drug Administration (FDA) clearance for its third, further expanded claim for the market-leading MALDI Biotyper-CA (MBT-CA) system for fast, accurate and cost-effective microbial identification. The new claim includes a significant expansion of the microbial reference library for clinical... Read more
Basel, 28 July 2017 FDA grants breakthrough therapy designation for Venclexta in acute myeloid leukaemia First in class BCL2-specific oral inhibitor represents a potential new way of treating acute myeloid leukaemia (AML), the most common type of aggressive leukaemia in adults1 17th breakthrough therapy designation for Roche’s portfolio of medicines and 4th for Venclexta Roche... Read more
Collaboration aims to strengthen training opportunities in the latest technologies for young researchers IPSWICH, Mass. and HEIDELBERG, Germany, July 25, 2017 /PRNewswire/ — The EMBL Advanced Training Centre (ATC) welcomes New England Biolabs (NEB®) as its newest member of their Corporate Partnership Programme. Founded in the mid-1970s as a collective of scientists committed to developing innovative products for the life... Read more